These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20167187)

  • 1. Amperometric glucose sensors: sources of error and potential benefit of redundancy.
    Castle JR; Ward WK
    J Diabetes Sci Technol; 2010 Jan; 4(1):221-5. PubMed ID: 20167187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of time point of calibration on accuracy of continuous glucose monitoring in individuals with type 1 diabetes.
    Zueger T; Diem P; Mougiakakou S; Stettler C
    Diabetes Technol Ther; 2012 Jul; 14(7):583-8. PubMed ID: 22512266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes.
    Castle JR; Pitts A; Hanavan K; Muhly R; El Youssef J; Hughes-Karvetski C; Kovatchev B; Ward WK
    Diabetes Care; 2012 Apr; 35(4):706-10. PubMed ID: 22357189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the error of continuous glucose monitoring sensor data: critical aspects discussed through simulation studies.
    Facchinetti A; Sparacino G; Cobelli C
    J Diabetes Sci Technol; 2010 Jan; 4(1):4-14. PubMed ID: 20167162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors.
    Mitre TM; Legault L; Rabasa-Lhoret R; Haidar A
    Diabetes Technol Ther; 2014 May; 16(5):326-7. PubMed ID: 24447013
    [No Abstract]   [Full Text] [Related]  

  • 6. Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system.
    Jungheim K; Wientjes KJ; Heinemann L; Lodwig V; Koschinsky T; Schoonen AJ;
    Diabetes Care; 2001 Sep; 24(9):1696-7. PubMed ID: 11522729
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to Mitre et al.: "analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors".
    Hovorka R; Nodale M
    Diabetes Technol Ther; 2014 May; 16(5):328-9. PubMed ID: 24690134
    [No Abstract]   [Full Text] [Related]  

  • 8. The MiniMed continuous glucose monitoring system.
    Mastrototaro JJ
    Diabetes Technol Ther; 2000; 2 Suppl 1():S13-8. PubMed ID: 11469627
    [No Abstract]   [Full Text] [Related]  

  • 9. Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia.
    Ward WK; Castle JR; El Youssef J
    J Diabetes Sci Technol; 2011 Nov; 5(6):1373-80. PubMed ID: 22226254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstrations and discussions of continuous glucose monitors.
    Bode BW
    Diabetes Technol Ther; 2005 Oct; 7(5):805-8. PubMed ID: 16241888
    [No Abstract]   [Full Text] [Related]  

  • 11. Accuracy of the Enlite 6-day glucose sensor with guardian and Veo calibration algorithms.
    Keenan DB; Mastrototaro JJ; Zisser H; Cooper KA; Raghavendhar G; Lee SW; Yusi J; Bailey TS; Brazg RL; Shah RV
    Diabetes Technol Ther; 2012 Mar; 14(3):225-31. PubMed ID: 22145851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multisite Study of an Implanted Continuous Glucose Sensor Over 90 Days in Patients With Diabetes Mellitus.
    Dehennis A; Mortellaro MA; Ioacara S
    J Diabetes Sci Technol; 2015 Jul; 9(5):951-6. PubMed ID: 26224762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time.
    Bailey T; Zisser H; Chang A
    Diabetes Technol Ther; 2009 Dec; 11(12):749-55. PubMed ID: 20001675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges for outpatient closed loop studies: how to assess efficacy.
    Beck RW; Calhoun P; Kollman C
    Diabetes Technol Ther; 2013 Jan; 15(1):1-3. PubMed ID: 23297669
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous glucose monitoring in subcutaneous tissue using factory-calibrated sensors: a pilot study.
    Hoss U; Jeddi I; Schulz M; Budiman E; Bhogal C; McGarraugh G
    Diabetes Technol Ther; 2010 Aug; 12(8):591-7. PubMed ID: 20615099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First application of a transcutaneous optical single-port glucose monitoring device in patients with type 1 diabetes mellitus.
    Rumpler M; Mader JK; Fischer JP; Thar R; Granger JM; Deliane F; Klimant I; Aberer F; Sinner F; Pieber TR; Hajnsek M
    Biosens Bioelectron; 2017 Feb; 88():240-248. PubMed ID: 27554063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical assessment and mathematical modeling of the accuracy of continuous glucose sensors (CGS).
    Kovatchev BP; King C; Breton M; Anderson S; Clarke W
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():71-4. PubMed ID: 17945569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of a transcutaneous interrogated fluorescence lifetime-based microsensor for continuous glucose reading.
    Nielsen JK; Christiansen JS; Kristensen JS; Toft HO; Hansen LL; Aasmul S; Gregorius K
    J Diabetes Sci Technol; 2009 Jan; 3(1):98-109. PubMed ID: 20046654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance evaluation of three continuous glucose monitoring systems: comparison of six sensors per subject in parallel.
    Freckmann G; Pleus S; Link M; Zschornack E; Klötzer HM; Haug C
    J Diabetes Sci Technol; 2013 Jul; 7(4):842-53. PubMed ID: 23911165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes.
    Wilinska ME; Chassin LJ; Acerini CL; Allen JM; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2010 Jan; 4(1):132-44. PubMed ID: 20167177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.